Accretion Pharmaceuticals, a Gujarat-based pharma manufacturer, concluded its SME IPO with a strong subscription of 7.31 times. The IPO, priced at Rs 96-101 per share, aims to utilize proceeds for capital expenditures and facility upgrades. Despite robust financial growth and international presence, the grey market premium remained flat, indicating market caution ahead of its NSE SME platform listing.
US Federal Reserve’s Anna Paulson sees scope for more interest rate hikes amid inflation risks
Philadelphia Federal Reserve President Anna Paulson indicated that additional interest rate hikes could be warranted to combat inflation. She stated that inflation remains persistently high,